488
Participants
Start Date
March 19, 2024
Primary Completion Date
August 20, 2025
Study Completion Date
August 20, 2025
Rcombinant botulinum neurotoxin type A for injection (YY001)
Five sites will be injected at 0.05 mL each, 2 sites in corrugator muscle of each side and 1 site in the procerus muscle, for a total dose of 20U.
Guangdong Second People's Hospital, Guangzhou
Nanfang Hospital, Southern Medical University, Guangzhou
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
The Third Xiangya Hospital of Central South University, Changsha
The Second Affiliated Hospital Of Xi'an Jiaotong University, Xian
West China School of Medicine/West China Hospital of Sichuan University, Chengdu
Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Hangzhou
Zhejiang Provincial People's Hospital, Hangzhou
Beijing Tsinghua Changgung Hospital, Beijing
Peking Union Medical College Hospital , Chinese Academy of Medical Sciences, Beijing
Peking University First Hospital, Beijing
Peking University Third Hospital, Beijing
Plastic Surgery Hospital, Chinese Academy of Medical Science, Beijing
The First Affiliated Hospital of Chongqing Medical University, Hongqing
Tianjin Medical University General Hospital, Tianjin
Chongqing Claruvis Pharmaceutical Co., Ltd.
INDUSTRY